These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38504479)

  • 21. Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis.
    Pu TY; Chuang KC; Tung MC; Yen CC; Chen YH; Cidem A; Ko CH; Chen W; Chen CM
    Biomed Pharmacother; 2024 May; 174():116490. PubMed ID: 38554526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes.
    Lebda MA; Sadek KM; Abouzed TK; Tohamy HG; El-Sayed YS
    Life Sci; 2018 Jan; 192():136-143. PubMed ID: 29180002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin attenuates thioacetamide-induced liver fibrosis in male rats through modulation of interleukin-6, interleukin-4, apoptosis and urokinase plasminogen activator receptor-associated protein/Endo180.
    Elhadidy MG; Elmasry AI; El Nashar EM; Alghamdi MA; Al-Khater KM; Alasmari WA; Eladl AE; Hamed EM; Almohawes ZN; El-Kott AF; Shati AA; Rabei MR; Elalfy MM
    J Physiol Pharmacol; 2022 Oct; 73(5):. PubMed ID: 36942808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
    Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C
    Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimethyl fumarate protects thioacetamide-induced liver damage in rats: Studies on Nrf2, NLRP3, and NF-κB.
    Dwivedi DK; Jena G; Kumar V
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22476. PubMed ID: 32060995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.
    Jantararussamee C; Rodniem S; Taweechotipatr M; Showpittapornchai U; Pradidarcheep W
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):40-50. PubMed ID: 32468435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective activity of a phytotherapeutic formula on thioacetamide--induced liver fibrosis model.
    Kantah MK; Kobayashi R; Sollano J; Naito Y; Solimene U; Jains S; Catanzaro R; Minelli E; Polimeni A; Marotta F
    Acta Biomed; 2011 Apr; 82(1):82-9. PubMed ID: 22069962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
    Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
    Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways.
    Vargas-Pozada EE; Ramos-Tovar E; Acero-Hernández C; Cardoso-Lezama I; Galindo-Gómez S; Tsutsumi V; Muriel P
    Ann Hepatol; 2022; 27(2):100671. PubMed ID: 35065262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betaine Modulating MIF-Mediated Oxidative Stress, Inflammation and Fibrogenesis in Thioacetamide-Induced Nephrotoxicity.
    Jorgačević B; Stanković S; Filipović J; Samardžić J; Vučević D; Radosavljević T
    Curr Med Chem; 2022 Aug; 29(31):5254-5267. PubMed ID: 35400322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats.
    Lee YH; Son JY; Kim KS; Park YJ; Kim HR; Park JH; Kim KB; Lee KY; Kang KW; Kim IS; Kacew S; Lee BM; Kim HS
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats.
    Ali SO; Darwish HA; Ismail NA
    Chem Biol Interact; 2014 Jun; 216():26-33. PubMed ID: 24704557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.
    Ling H; Roux E; Hempel D; Tao J; Smith M; Lonning S; Zuk A; Arbeeny C; Ledbetter S
    PLoS One; 2013; 8(1):e54499. PubMed ID: 23349909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
    Shaker ME; Shiha GE; Ibrahim TM
    Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model.
    Sharawy MH; El-Awady MS; Makled MN
    J Biochem Mol Toxicol; 2021 May; 35(5):e22745. PubMed ID: 33749060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Protective Effect of SLNP on Hepatic Fibrosis Induced by Thioacetamide in Rats.
    Wu L; Liu J; Zheng C; Ma H; Cao X; Huang Z; Tian K
    Curr Pharm Des; 2023; 29(37):2988-2995. PubMed ID: 37936451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models.
    Ezhilarasan D
    Environ Toxicol Pharmacol; 2023 Apr; 99():104093. PubMed ID: 36870405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.
    Eraky SM; El-Mesery M; El-Karef A; Eissa LA; El-Gayar AM
    Biomed Pharmacother; 2018 May; 101():49-57. PubMed ID: 29477472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.